On the leading edge of Personalized Medicine and Big Data Analytics for >18 years, Iris has worked for or consulted for top Big Pharma (VP), startup (Chief Scientific Officer) and consultancies. She specializes in leveraging human genetics, translational medicine and eHealth to drive and augment the discovery, development and lifecycle management of biopharmaceutical assets. She has built and led R&D organizations, spearheaded IP and talent strategies, novel modality exploration and forging multi-year strategic research partnerships across a broad spectrum of diseases, chiefly neurological, autoimmune, metabolic and others.
Dr. Grossman is a member of the Scientific Advisory Boards of BC Platforms, Eleven therapeutics and CGRP Diagnostics, and is a Steering Committee member of the Tipa biobank.
• BSc: medical sciences (Technion)
• PhD: medicine and pharmacogenetics (under auspices of the MD/PhD program at the Technion, co-mentored with the Weizmann Institute)
• Post-doc: Personalized Medicine and Population Genomics (Duke)
On the leading edge of Personalized Medicine and Big Data Analytics for >18 years, Iris has worked for or consulted for top Big Pharma (VP), startup (Chief Scientific Officer) and consultancies. She specializes in leveraging human genetics, translational medicine and eHealth to drive and augment the discovery, development and lifecycle management of biopharmaceutical assets. She has built and led R&D organizations, spearheaded IP and talent strategies, novel modality exploration and forging multi-year strategic research partnerships across a broad spectrum of diseases, chiefly neurological, autoimmune, metabolic and others.
Dr. Grossman is a member of the Scientific Advisory Boards of BC Platforms, Eleven therapeutics and CGRP Diagnostics, and is a Steering Committee member of the Tipa biobank.
• BSc: medical sciences (Technion)
• PhD: medicine and pharmacogenetics (under auspices of the MD/PhD program at the Technion, co-mentored with the Weizmann Institute)
• Post-doc: Personalized Medicine and Population Genomics (Duke)